Based on the Innovent Biologics Inc stock forecast from 0 analysts, the average analyst target price for Innovent Biologics Inc is not available over the next 12 months. Innovent Biologics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Innovent Biologics Inc is Very Bullish, which is based on 1 positive signals and 0 negative signals. At the last closing, Innovent Biologics Inc’s stock price was USD 5.42. Innovent Biologics Inc’s stock price has changed by +8.40% over the past week, +17.32% over the past month and +12.68% over the last year.
No recent analyst target price found for Innovent Biologics Inc
No recent average analyst rating found for Innovent Biologics Inc
Company Overview Innovent Biologics Inc
N/A
N/A
N/A
N/A
USD
CHN
Adjusted Closing Price for Innovent Biologics Inc (IVBXF)
Loading...
Unadjusted Closing Price for Innovent Biologics Inc (IVBXF)
Loading...
Share Trading Volume for Innovent Biologics Inc Shares
Loading...
Compare Performance of Innovent Biologics Inc Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for IVBXF
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Innovent Biologics Inc (Sector: Biotechnology )
Frequently Asked Questions About Innovent Biologics Inc (IVBXF) Stock
Stock Target Advisor's fundamental analysis for Innovent Biologics Inc's stock is Very Bullish.
Unfortunately we do not have enough data on IVBXF's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on IVBXF's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on IVBXF's stock to indicate if its overvalued.
The last closing price of IVBXF's stock was USD 5.42.
Unfortunately we do not currently have any market capitalization data for IVBXF's stock.
Unfortunately we do not have enough analyst data on IVBXF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Innovent Biologics Inc's stock.
Sorry, we do not have any data on the number of employees for Innovent Biologics Inc.
Sorry we do not have any infomation available on Innovent Biologics Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IVBXF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
